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and regulatory cells of Peripheral 
lymph node and Peyer’s Patches
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Bernard Malissen2, Gabriela G. Loots3, Reinhold Förster1 and Günter Bernhardt1*
1 Institute of Immunology, Hannover Medical School, Hannover, Germany, 2 Centre d’Immunologie de Marseille-Luminy,  
Aix Marseille Université, INSERM, CNRS, Marseille, France, 3 Biology and Biotechnology Division, Lawrence Livermore 
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Follicular helper (TFH) and regulatory (TFR) cells are critical players in managing ger-
minal center (GC) reactions that accomplish effective humoral immune responses. 
Transcriptome analyses were done comparing gene regulation of TFH and TFR cells iso-
lated from Peyer’s Patches (PP) and immunized peripheral lymph nodes (pLNs) revealing 
many regulatory patterns common to all follicular cells. However, in contrast to TFH cells, 
the upregulation or downregulation of many genes was attenuated substantially in pLN 
TFR cells when compared to those of PP. Additionally, PP but not pLN TFR cells were 
largely unresponsive to IL2 and expressed Il4 as well as Il21. Together with fundamental 
differences in gene expression that were found between cells of both compartments 
this emphasizes specific adaptations of follicular T cell functions to their micro-milieu. 
Moreover, although GL7 expression distinguishes matured follicular T cells, GL7+ as well 
as GL7− cells are present in the GC.
Keywords: follicular helper T cells, follicular regulatory T cells, lymph node, Peyer’s patch, transcriptome, germinal 
center
inTrODUcTiOn
In the course of an adaptive immune response, some of the antigen primed CD4 T cells differentiate 
into follicular helper T (TFH) cells (1). This occurs in a stepwise process (2). Already at the initial 
contact of a cognate CD4 T cell with an antigen presenting dendritic cell (DC) a first commitment 
toward TFH differentiation is made as reflected by an early upregulation of key genes of this pathway, 
such as Bcl6 (3, 4), Ascl2 (5), ICOS (6, 7), PD1 (8), or BATF/c-Maf (9). This is accompanied by 
the downregulation of CCR7 expression and a concomitant upregulation of CXCR5 guiding the 
Bcl6intPD1int preTFH cells to the T/B border area (2), where they can contact antigen activated B cells. 
Proper signals received by the cognate B cells then trigger further upregulation of markers, such as 
BCL6, PD1, ICOS, and CXCR5 completing the TFH cell differentiation program that ultimately leads 
to the migration of the TFH cells into the B cell follicle and the founding of a germinal center (GC). 
In contrast, inadequately stimulated preTFH cells could assist B cells fostering an early antibody 
response whereas cells that failed to come into contact with antigen may develop into TH2 cells 
(10). Fully matured TFH cells are defined as Bcl6hiPD1hiICOShiCXCR5hiCCR7lo cells but a wealth of 
other markers may be included that where shown to be down or upregulated in TFH cells such as 
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KLF2 (11), IL4 (10), or IL21 (12). The final differentiation into GC 
TFH cells is flexible: the cells may revert to a more immature stage 
becoming memory cells (13) that can circulate in blood and may 
give rise to effector helper T and TFH cells in the course of a recall 
response (14, 15). Moreover, GC TFH cells are not restricted to 
their GC but can travel to neighboring GC inside the secondary 
lymphoid organ (16).
The GC reaction is a highly dynamic process and must be 
tightly controlled in order to prevent the exuberant production 
of antibodies and autoimmunity. In part, this is accomplished by 
follicular regulatory T (TFR) cells (17, 18). TFR cells develop from 
natural regulatory T (Treg) cells and possess a TCR repertoire 
different from that of the TFH cells originating from the same 
antigenic challenge (19). Yet phenotypically, TFR cells closely 
resemble TFH cells. To some degree this is dictated by the need to 
be present at the same location, the GC, as the cells to be controlled, 
the GC TFH and B cells. Thus, TFR cells were also described as 
Bcl6+PD1+CXCR5hiCCR7lo cells but in addition express Foxp3, the 
master transcription factor managing their inhibitory potential. 
Like TFH cells, memory TFR cells circulate in blood (20).
Peyer’s Patches (PP) differ from peripheral lymph nodes 
(pLNs) in several aspects (21): PP do not possess afferent lym-
phatics but receive antigen directly from the lumen of the gut 
that is rich in commensal bacteria. Gut contents are transported 
via M cells into the PP and taken up by DC residing in the sub-
epithelial dome that process and present antigen to T cells. The 
continuous exposure of PP cells to bacterial constituents keeps 
the GC inside PP under constant operation. On the other hand, 
the intestinal immune compartment is tolerogenic by nature 
thus preventing unwanted immune reactivity against otherwise 
harmless antigens (22). Moreover, the main antibody produced 
by PP derived plasma cells is IgA whereas switch to an IgG class 
is usually performed by B cells in pLN where GC emerge only on 
demand. These differences render it likely that TFH and TFR cells 
of PP might differ from their counterparts in pLN in handling a 
GC reaction. This is evidenced by the finding that in PP but not 
pLN Treg cells can develop via a TFR stage into TFH cells (23, 24).
Here, we explored the characteristics of pLN and PP derived 
TFH as well as TFR cells based on analysis and comparison of 
their transcriptomes. Expectedly, TFR cells resemble TFH cells 
but in pLN the follicular phenotype as compared to PP TFR cells 
remains incomplete regarding many genes. The latter not only 
gradually differed from pLN TFR cell but also fundamentally in 
several aspects. PP TFR cells produce IL4 and to some extent also 
IL21. Moreover, in contrast to pLN TFR cells, PP TFR cell can-
not propagate in response to IL2 because they lack expression of 
CD25. We also show that in PP GC follicular T cells are promiscu-
ous with regard to expression of the GL7 epitope disqualifying it 
as an exclusive marker for GC resident cells.
MaTerials anD MeThODs
Mice
C57BL/6NCrl (B6) mice were originally purchased from Charles 
River (Strain number: 027) and B6.Cg-Ptprca Tg(UBC-PA-
GFP)1Mnz Ptprca-Pepcb/Boy (PA-GFP) mice from Jackson 
Laboratories (Strain number: 022486). B6.Cg-Foxp3<tm1Mal> (Foxp3) 
mice were provided by B. Malissen (Aix-Marseille Université, 
Marseille, France) and B6.Sostdc1tm1(KOMP)Vlcg (Sostdc1−/−) mice by 
G. Loots (Lawrence Livermore National Laboratory, Livermore, 
USA). All mice were bred at the central animal facility at Hannover 
Medical School (MHH) under specific pathogen-free conditions. 
Females and males, 7- to 12-week-old mice were used in all 
experiments.
immunizations
To induce development of GCs and follicular CD4 T  cells, 
mice were immunized subcutaneously (s.c.) into both flanks 
with 200  µg keyhole limpet hemocyanin (KLH) mixed with 
Alhydrogel adjuvant 2% (Alum) at 1:1 v:v ratio in 100 µl volume. 
Post immunization mice were sacrificed at the indicated time 
points and draining lymph nodes (iLNs) were harvest for further 
analysis.
Flow cytometry and cell sorting
Organs were harvested on ice in FACS buffer (PBS/3% FCS) 
and single-cell suspensions were prepared by meshing through 
40-µm cell strainers. Prior staining samples are blocked with 
3% rat serum in FACS buffer. All surface stainings were done 
on ice for 30 min, except for CCR7 that was performed at 37°C 
for 30 min. Intracellular cytokine stainings were done using the 
ICS staining buffer set (eBioscience cat# 88-8824-00) and intra-
cellular detection of FOXP3 was performed by using a FOXP3 
staining buffer set (eBioscience cat# 00-5523-00), following the 
protocol provided by the manufacturer. The complete list of all 
antibodies used in this study is: anti-mouse CD19 (clone 6D5), 
anti-mouse CD4 (clone RM4-5), anti-mouse IFN-γ (clone 
XMG1.2), anti-mouse IL-17A (clone TC11-18H10.1), anti-
mouse CD8α (clone 53-6.7), anti-human/mouse CD49f (clone 
GoH3), anti-mouse CD196 (CCR6) (clone 29-2L17), anti-mouse 
Syndecan-1 (CD138) (clone 281-2), anti-mouse CD3 (clone 
17A2), IgG1, κ Isotype Ctrl Antibody (clone RTK2071), IgG2a, 
κ Isotype Ctrl Antibody (clone RTK2758), IgG2b, κ Isotype Ctrl 
Antibody (clone RTK4530), IgG Isotype Ctrl Antibody (clone 
HTK888) all from BioLegend; anti-human/mouse CD45R (B220) 
(clone RA3-6B2), anti-mouse CD95 (APO-1/Fas) (clone 15A7), 
anti-mouse IL10 (clone JES5-16E3), anti-mouse CD279 (PD-1) 
(clone J43), anti-mouse CD197 (CCR7) (clone 4B12), anti-mouse 
CD278 (ICOS) (clone 7E.17G9), anti-mouse CD185 (CXCR5) 
(clone SPRCL5), anti-mouse CD25 (clone PC61.5), anti-human/
mouse GL7 (clone GL7), anti-mouse/rat FOXP3 (clone FJK-16s) 
all from eBioscience; anti-mouse IL-4 (clone 11B11) and anti-
mouse T- and B-Cell Activation Antigen (GL7) (clone GL7) from 
BD Bioscience; anti-rat/mouse CD29 (Itgb1) (clone HMß1 1) 
from Miltenyi Biotec. Anti-mouse IgD (clone HB250) was 
in-house produced. Data were acquired on LSR II (Becton and 
Dickinson) and analyzed with FlowJo version 10.1r5 (Tree Star). 
For cell sorting, single-cell suspensions from pooled pLNs or PP 
were prepared and stained as described above. Cells were sorted 
into RPMI 1640/10% FCS medium utilizing FACSAria Fusion 
(Becton Dickinson) or MoFlo XDP (Beckman-Coulter) cell 
sorters. Cell fractions are pre-gated on singlets and collected as 
follows: Naïve CD4 T cells (DAPI−B220−CD4+GFP−PD1−GL7−); 
3Georgiev et al. Follicular T Cells
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 714
TFH GL7− (DAPI−B220−CD4+GFP−PD1hiGL7−); TFH GL7+  
(DAPI−B220−CD4+GFP−PD1hiGL7+); Tregs (DAPI−B220−CD4+ 
GFP+PD1−GL7−); and TFR cells (DAPI−B220−CD4+GFP+PD1hi 
GL7+/−).
In Vitro cytokine Production
Organs were harvested in RPMI 1640/10% FCS medium sup-
plemented with 10  µM KN-62. Total cell preparations were 
plated at density of 5 × 106/ml and incubated at 37°C for 4 h in 
RPMI 1640/10% FCS medium supplemented with 10 µM KN-62, 
Ionomycin 1.5 µg/ml (Invitrogen cat# I-24222), PMA 50 ng/ml 
(Calbiochem cat# 524400) and Brefeldin A 10  µg/ml (Sigma-
Aldrich cat# B6542). During this step control cells are kept on ice 
in FACS buffer. Following incubation samples were processed for 
intracellular cytokine stainings by flow cytometry as described 
above.
In Vitro cell Proliferation assay
Peyer’s Patches and pLNs (d12 p.i. with KLH +  Alum) were 
harvested in RPMI 1640/10% FCS medium supplemented 
with 10-μM KN-62. Single-cell suspensions were prepared and 
TFH, TFR, and Treg cells were sorted according to the gating 
strategy depicted in Figures S1A,B in Supplementary Material. 
Sorted cells were labeled with Cell Proliferation Dye eFluor® 670 
(eBioscience cat# 65-0840-90) following the guidance provided 
from the manufacturer. Following labeling cells were plated in 
RPMI 1640/10% FCS medium supplemented with recombinant 
IL2 100U/l at a density of 5 × 105/ml into wells that were coated 
with 1 µg/ml anti-mouse CD3 antibody (clone 17A2). 4 days post 
plating, cells were analyzed with the use of flow cytometry for 
frequencies of proliferated cells.
enzyme-linked immunosorbent assay 
(elisa)
For analysis of IgA titers in fecal samples, specimens were col-
lected at two different time points from each animal separately. 
ELISA plates were coated overnight at 4°C with 500 ng goat anti-
mouse IgA (BIO-RAD cat# StAR137) in PBSd per well. Weight of 
stool samples was determined and PBSd was added to obtain 10% 
w/v suspensions. The suspensions were centrifuged and super-
natant dilutions (as indicated in Figure 7E) were added to the 
plates and incubated for 1 h at 37°C. For detection of IgA levels, 
the following secondary antibodies were used: goat anti-mouse 
kappa light chain antibody HRP conjugated (Merck Millipore 
cat# AP200P) and goat anti-mouse lambda light chain antibody 
HRP conjugated (Bethyl cat# A90-121P).
isolation of rna and Microarray assay
Naïve CD4 T cells, Tregs, TFH, and TFR cells were FACS sorted 
from pooled PP or pLNs from 8 to 15 mice at day 12 or day 25 post 
s.c. immunization with KLH + Alum. Following sorting RNA was 
isolated using the RNeasy Plus Micro Kit (Qiagen).
The Microarray study has been performed by use of refined 
versions of the Whole Mouse Genome Oligo Microarray 
4x44K v2 (Design ID 026655, Agilent Technologies), called 
“026655AsQuadruplicatesOn4x180K” (Design ID 048306) or 
“048306On1M_V3” (Design ID 084107). Both Microarray 
designs are developed by the Research Core Unit Genomics of 
Hannover Medical School. Microarrays of these design types 
cover roughly 32,000 murine transcripts. Microarray designs 
were defined at Agilent’s eArray portal using a 4x180K, or a 
1  M design format for mRNA expression as template. All 
non-control probes of design ID 026655 have been selected 
to be printed four times onto one area covering 180K probes 
(yielding in on-chip quadruplicate Features). Control probes 
required for proper Feature Extraction software operation were 
determined and placed automatically by eArray using recom-
mended default settings.
25–40  ng of total RNA were used to prepare aminoallyl-
UTP-modified (aaUTP) cRNA (Amino Allyl MessageAmp™ II 
Kit; #AM1753; Life Technologies) as directed by the company 
(applying one-round of amplification), except that reaction 
volumes were halved. The labeling of aaUTP-cRNA was 
performed by use of Alexa Fluor 555 Reactive Dye (#A32756; 
LifeTechnologies). Prior to the reverse transcription reaction, 
1 µl of a 1:100,000 dilution of Agilent’s “One-Color spike-in Kit 
stock solution” (#5188-5282, Agilent Technologies) was added 
to a subset of total RNA sample.
cRNA fragmentation, hybridization and washing steps were 
carried-out as recommended in the “One-Color Microarray-
Based Gene Expression Analysis Protocol V5.7,” except that 
250–300 ng of each fluorescently labeled cRNA population were 
used for hybridization.
Slides were scanned on the Agilent Micro Array Scanner 
G2565CA (pixel resolution 3 µm, bit depth 20). Data extraction 
was performed with the “Feature Extraction Software V10.7.3.1” 
using the extraction protocol file “GE1_107_Sep09.xml.”
Measurements of on-chip replicates (quadruplicates) were 
averaged using the geometric mean of processed intensity values 
of the green channel, “gProcessedSignal” (gPS) to retrieve one 
resulting value per probe and sample. Single Features were 
excluded from averaging, if they (i) were manually flagged, (ii) 
were identified as Outliers by the Feature Extraction Software, (iii) 
lay outside the interval of “1.42 × interquartile range” regarding 
the gPS distribution of the respective on-chip replicate popula-
tion, or (iv) showed a coefficient of variation of pixel intensities 
per Feature that exceeded 0.5.
Averaged gPS values were normalized by quantile normaliza-
tion first, followed by global linear scaling. For this latter approach, 
all gPS values of one sample were multiplied by an array-specific 
scaling factor. This factor was calculated by dividing a “refer-
ence 75th Percentile value” (set as 1,500 for the whole series) 
by the 75th Percentile value of the particular Microarray to be 
normalized (“Array I” in the formula shown below). Accordingly, 
normalized gPS values for all samples (microarray data sets) were 
calculated by the following formula:
 
normalized gPSArray gPSArray  
 1,5 75th PercentileAr
i i=
× 00 / ray i( ).  
A lower intensity threshold (surrogate value) was defined 
based on intensity distribution of negative control features. This 
value was fixed to 20. All of those normalized gPS values that fell 
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below this intensity border were substituted by the respective 
surrogate value of 20.
Data availability
RNA data have been deposited in the National Center for 
Biotechnology Information GEO database (https://www.ncbi. 
nlm.nih.gov/geo) under the GEO accession number GSE106593.
Two-Photon Photoactivation and 
epifluorescence Microscopy
For in  situ photoactivation, B6.Cg-Ptprca Tg(UBC-PA-
GFP)1Mnz Ptprca-Pepcb/Boy (PA-GFP) mice were sacrificed, 
PP were explanted and immobilized serosal side facing upwards 
on a plastic Petri dish using tissue adhesive glue (Surgibond). 
In total, 7 PP per mouse were explanted: three were kept on ice 
in FACS buffer as controls four were used for photoactivation of 
a small region in GCs or in the interfollicular region.
A 2-photon laser tuned to 825 nm (with low energy inten-
sity) was used to localize the GC. Beneath the serosal collagen, 
a layer of autofluorescent macrophages outlines the outer part 
of the GC as illustrated in Figures  6B,C. Starting directly 
under the autofluorescent macrophage layer, cuboids with the 
dimension of 100–200  µm and 40  µm in depth were treated 
with the 2-photon laser at 825 nm (with high energy intensity). 
In every PP, three B cell follicles were photoactivated. The size 
of each cuboid was matched to the size of the follicle, GC 
orientation and proximity to vessels (Figures  6B,C). For the 
two-photon treatment of the interfollicular region, a cube with 
the dimension of 100 µm × 100 µm × 40 µm was converted in 
the area between two B cell follicles (Figures 6B,C). The treated 
samples were imaged using a Leica epifluorescence microscope 
to validate positioning of the treated regions. Finally, single-cell 
suspensions were prepared from each PP and flow cytometry 
analysis was performed (Figure 6D).
Bioinformatics and statistical analysis
The heat maps and the PCA analysis shown in Figure 2 were 
generated by Qlucore Omics Explorer software tool from the 
normalized gPS values for selected genes. The n values equal 
4–7 animals per group in Figures  1A–D, 3A,D, 4, 5B, and 
7C–F, and three animals in Figures  6C–F. In Figures  6E,F, 
each dot represents single PP. For the transcriptome analysis 
(Figures  1E, 2, 3B,C, 5A, 6A, and 7A,B; Figures S1C, S2, 
and S4 in Supplementary Material), each cell fraction (where 
n = cell fraction) is sorted from pooled organs harvest from 7 to 
8 mice (n = 2 in PP and day 25, and n = 3 in day 12). All animals 
in this study were analyzed at the age of 8–14 weeks old. Mean 
values of each group are shown in all figures and error bars 
represent ±  SD. All statistical analyses were performed with 
GraphPad Prism 4. One-way ANOVA followed by Tukey’s 
post  hoc analyses were performed in Figures  1E, 3B,C, 5A, 
and 7A,B; Figures S1C, S2 and S4 in Supplementary Material. 
Unpaired two-tailed t-test was done in Figures 6A and 7D–F 
and paired two-tailed t-test was done in Figure 6F as indicated 
in the legends of the figures.
resUlTs
Flow cytometry of Follicular cD4 T cells 
in PP and pln
Gating of CD4 T  cells of PP using standard markers PD1 and 
ICOS or CXCR5 discriminated three distinct populations: PD1lo, 
PD1int, and PD1hi (Figure  1A), a pattern highly similar to that 
found in human tonsils (25). Whereas populations in gates 2 and 
3 appeared uniform under these conditions, a stain including the 
carbohydrate epitope GL7 allowed a further dissection into GL7− 
(2a, 3a) and GL7+ (2b, 3b) subpopulations (Figure 1A). The GL7 
epitope was suggested to be present only on TFH cells inside the 
GC (26) but it is expressed by CD4 T cells already early following 
immunization at times when GC do not yet exist (27). Therefore, 
PD1intGL7+ cells most likely represent preTFH cells whereas the 
PD1intGL7− pool consists of additional cells such as Treg and 
effector helper cells. In support of this, only few PD1int cells were 
detectable in the GL7+ gate in steady state pLN (Figure 1B, d0) but 
came into existence upon immunization (≥d6). In general, the very 
same gating strategy as applied for PP can be used to identify TFH 
or preTFH cells in immunized pLN of B6 mice (Figure 1B). On 
d6 post immunization (p.i.), a prominent PD1hiGL7− population 
was formed but diffuse PD1int/hiGL7+ clusters were also present. 
At d12, a distinct PD1hiGL7+ population emerged whereas less 
PD1hiGL7− cells existed. This distribution remained unchanged at 
d25 but less PD1intGL7+ cells were present.
A considerable proportion of CD4 T cells consist of Treg cells. 
Therefore, the strain C57BL/6-Foxp3EGFP (Foxp3 mouse) (28) was 
used allowing a separate analysis of Foxp3 expressing cells. The 
PD1/GL7-distribution pattern of PP CD4+Foxp3+ cells resembled 
remarkably that of the CD4+Foxp3− cells (Figure  1C). Again, 
PD1hi cells were virtually undetectable in non-immunized pLN 
(Figure 1D) and also CD4+GL7+ cells were only rarely observed. 
However, a small but noticeable fraction of PD1int Treg cells was 
found representing activated cells (29).
Transcriptome analysis of cD4 Follicular  
T cells
To elucidate potential differences between follicular T  cells 
in pLN versus PP, transcriptome analyses were done by sort-
ing cells from PP or pLN at d12 and d25 p.i. of Foxp3 mice. 
A gating strategy applied as shown in Figures  1C,D was used 
to obtain GFP−PD1loGL7− (naïve T), GFP+PD1loGL7− (Treg), 
GFP−PD1hiGL7+ (TFH), and GFP+PD1hiGL7+/− (TFR) cells, 
respectively, from immunized pLN. Cells of PP origin were sorted 
accordingly but instead of naïve T  cells, GFP−PD1hiGL7− cells 
were isolated. RNA from sorted cells was processed, hybridized 
on Agilent chips (see Materials and Methods) and the results 
deposited in the GEO database (accession number: GSE106593). 
The purity of the sorts was usually ≥95% (Figures S1A,B in 
Supplementary Material) and all PD1hi cells obtained by the 
applied gating strategy were also CXCR5+ (data not shown, see 
also Figure 1A). Purity is further illustrated by genes like Lrrc32 
that is expressed specifically by Treg cells (30) (Figure S1C in 
Supplementary Material). Inversely, expression of Pde3b, coding 
FigUre 1 | Characterization of follicular CD4 T cells. (a–D) Flow cytometry profiles of different TFH cell markers as indicated expressed on CD4 T cells from Peyer’s 
Patches (PP) and peripheral lymph node (pLN) 6, 12, or 25 days p.i. with KLH + Alum. Data are representative of at least two independent experiments with three animals 
per time point. (e) Microarray evaluation of mRNA expression levels of selected genes. For sorts, material from 8 to 15 mice was pooled in each case before RNA was 
isolated and processed. Data source [and Gene Expression Omnibus (GEO) accession number] as described in the text and in Section “Materials and Methods.” RU 
represents relative expression strength. Shown are mean ± SD (n = 2 in PP and d25, and n = 3 in d12). Data in (a,B) are from B6 mice and in (c–e) from Foxp3 mice. 
One-way ANOVA followed by Tukey’s post hoc analysis was performed in (e). N/A: not applicable, ns: not significant (p > 0.05), *p < 0.05, **p < 0.01, and ***p < 0.001.
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FigUre 2 | Expression patterns of CD4 T cell subsets from Peyer’s Patches (PP) and immunized peripheral lymph node (pLN). (a) A PCA analysis was done based 
on the expression of 8,359 most differentially transcribed genes with p < 0.001 and a q-value cutoff 0.005 with the q-value describing the false discovery rate. 
Definition of the cell subtypes as described in the text. (B–D) Heat maps illustrating regulation of mRNA expression of selected genes listed to the right. Same data 
source as in Figure 1e.
6
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FigUre 3 | Protein and mRNA levels of selected genes in CD4 T cell subsets. (a,D) Surface expression of integrin α6 and β1 as well as CCR6 on the indicated cell 
types from Peyer’s Patches (PP) and peripheral lymph nodes (pLNs) at d12 p.i. with KLH + Alum. Data are representative of at least two independent experiments 
with n ≥ 2 animals per experiment. (B,c) Microarray data for mRNA expression levels of the depicted genes. Same data source as in Figure 1e. Shown are 
mean ± SD. One-way ANOVA followed by Tukey’s post hoc analysis was performed in (B,c) N/A: not applicable, ns: not significant (p > 0.05), *p < 0.05, 
**p < 0.01, and ***p < 0.001.
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a cyclic nucleotide phosphodiesterase, is low in Foxp3+ cells. Its 
downregulation is controlled by FoxP3 and essential for Treg 
cell homeostasis (31). Typical signature genes regulated during 
differentiation of TFH and TFR cells display the expected pattern 
(Figure  1E) such as the coordinated switch in the Ccr7/Cxcr5 
balance. Downregulation of Klf2 that would otherwise induce 
expression of Sell (CD62L), S1pr1, as well as Selplg (PSGL1) and 
repress that of Bcl6 is a key event in the TFH pathway (11). A sali-
ent regulation was also observed for genes directly (e.g., Ptpn11, 
Satb1, Stx11) or indirectly (e.g., Tbc1d4, Hif1a, Mafg) affecting 
performance of T cells. IL17 plays a role in correct positioning of 
TFH cells in the light zone (32). This is mediated in part by IL17-
driven upregulation of Rgs16, a regulator of G protein signaling 
rendering the cell unresponsive to CXCR4 triggered chemotaxis. 
In accordance with this, expression of Sytl1 (SLP1) that promotes 
cell migration via the CXCR4/CXCL12 axis was downregulated 
in TFH cells. However, Sytl1 was not downregulated in pLN TFR 
cells and only partially in PP TFR cells. Tsc22d3 (GILZ) regulates 
TH17 cell differentiation (33) and its downregulation might influ-
ence development of IL17 producing TFH cells. This may also 
apply to the role of IL1 that is involved in TH17 differentiation 
(34). A delicate balance seems to exist regarding sensitivity to IL1 
signaling since both, the functional Il1r1 and the decoy receptor 
Il1r2 are upregulated in TFH and TFR cells yet to a diverging 
extent depending on time and location.
A PCA analysis of the transcriptomes that is based on over 8,000 
most diversely transcribed genes illustrates that follicular T cells 
clearly differ from their progenitors (naïve T and Treg cells) but 
also indicates that neither TFH cells nor TFR cells of pLN and PP 
origin cluster together. However, TFH cells of both compartments 
appear more closely related to each other than the corresponding 
TFR cells (Figure 2A). The heat maps shown in Figures 2B–D 
depict genes exerting considerable regulation of their expression 
during differentiation into follicular T  cells. Only exemplary 
genes were selected where published evidence supports a role in 
T cell functionality or TFH cell differentiation and/or function. 
The genes listed were grouped into those that were found to be 
upregulated (B) or downmodulated (C) in follicular cells. A third 
category of genes (D) did not obey a simple regulatory scheme.
Delayed or attenuated regulation of 
genes in Follicular T cells
A coherent degree of regulation was observed for TFH and TFR 
cells of PP as well as pLN origin in many cases (Figure 1E, e.g., 
S1pr1, Satb1, Ptpn13, Ccr7, Tsc22d3). However, the expression 
profiles also revealed diverging tendencies for many genes. 
Although regulation of these genes in TFH cells was in general 
similar in extent in cells of PP and pLN origin (Figures 1E and 
2B,C), the degree of regulation in TFR cells was heterogeneous 
depending on their origin. Except for rare cases (e.g., Ptpn11 and 
Cxcr5), PP TFR cells resembled PP TFH or pLN TFH cells. Yet, a 
broad spectrum of genes displayed a significantly smaller degree 
of regulation in pLN TFR cells when compared to PP TFR cells 
and this discrepancy continued to exist in d25 cells (e.g., Bcl6, 
Stx11, Gadd45b, Hif1a, Cxcr5, Rgs16, Il1r1). In some instances, 
however, regulation of genes in d25 TFR cells reached the level 
met in PP TFR cells (e.g., Klf2, Sell, Tbc1d4). The heat maps in 
Figures  2B,C visualize further examples of complete versus 
incomplete or delayed regulation in TFR cells of pLN origin. 
Along with the global PCA analysis (Figure  2A), this suggests 
not only a retarded differentiation schedule generating matured 
pLN TFR cells (as compared to PP TFR and PP/pLN TFH cells) 
but also an attenuated regulation depending on the particular 
FigUre 4 | Cytokine profiles of TFH and TFR cells from Peyer’s Patches (PP) and peripheral lymph node (pLN). Total cell preparations from PP and pLNs d6,  
d12, and d25 p.i. were in vitro stimulated with PMA/ionomycin in the presence of Brefeldin A, followed by intracellular detection of the indicated cytokines by flow 
cytometry. (a) Representative plots depicting expression of IL4, IL10, IL17, and IFNγ by TFH and TFR cells of PP or pLN 12 days p.i. as indicated are shown.  
(B) Summary of (a) (shown are mean ± SD). (c) 3D representation of time kinetics of cytokine production by pLN TFH and TFR cells from d6, d12, and d25  
p.i. with KLH + Alum. Data from PP cells are also shown. Frequencies of positive cells are measured via intracellular detection of cytokines by flow cytometry as  
in (a). Data were combined from two independent experiments with two mice per experiment for each time point. Shown are mean values.
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gene investigated. This may manifest itself in specific variations 
in functionality. For instance, it was proposed that a low level of 
CXCR5 expression by TFR cells localizes them more to the border 
of the GC (35).
genes expressed Differently by cD4  
T cells From PP and pln
We identified genes that are expressed in a compartment specific 
manner and affected not only TFH and TFR cells but also Treg cells 
(Figure S2 in Supplementary Material). S100a4, Gcnt1 (C2GNT, 
a glucosaminyl transferase), and Fut7 (FUC-TVII, fucosyl trans-
ferase 7) were expressed predominantly by pLN cells whereas PP 
cells expressed mainly Dhrs3 and Sun5. Activity of C2GNT and 
FUC-TVII is required for formation of a functional P/E-selectin 
ligand in T cells (36). Despite downregulation of Selplg (PSGL1) 
in TFH/TFR cells (Figure 1E) a considerable basal level of expres-
sion persisted. Thus, the absence of FUC-TVII and C2GNT in 
PP cells would render any remaining PSGL1 driven binding 
activity to selectins non-functional. Interestingly, the vitamin A 
metabolite all-trans retinoic acid (RA) produced abundantly by 
FigUre 5 | IL2 responsiveness of TFR cells. (a) Microarray data for mRNA expression levels of Il2ra. Same data source as in Figure 1e. Shown are mean ± SD.  
(B) Expression levels of CD25 on the indicated cell types from Peyer’s Patches (PP) and peripheral lymph nodes (pLNs) d12 p.i. with KLH + Alum. Shown are 
representative flow cytometry histograms of two independent experiments with n = 6. (c) Cell proliferation assay of sorted cell types as indicated, labeled with cell 
proliferation dye and in vitro cultured on anti-CD3 coated plates in presence of IL2. Shown are representative flow cytometry plots of two independent experiments 
with pooled material sorted from eight mice per experiment. One-way ANOVA followed by Tukey’s post hoc analysis was performed in (a). N/A: not applicable, ns: 
not significant (p > 0.05) and **p < 0.01.
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intestinal cells counteracts Fut7 expression but induces that of 
Dhrs3 that is involved in RA metabolism. In addition, vitamin 
D impairs formation of selectin ligands (36) and expression of 
Vdr (vitamin D receptor) is upregulated in TFH cells and PP 
TFR cells. This suggests that local availability of compounds like 
vitamins influence the function of follicular but also Treg cells.
Peyer’s Patches T cells had uniformly low levels of Itgb1 (CD29) 
whereas among pLN cells expression of this integrin chain was 
heterogeneous (Figure S2 in Supplementary Material). Flow 
cytometry confirmed that the vast majority of PP cells expressed 
moderately this integrin on the surface whereas in pLN TFH and 
predominantly TFR cells expressed higher levels (Figure  3A; 
Figure S3 in Supplementary Material illustrates gating defining 
the cell subtypes). Also with regard to Itga6 (CD49f), PP TFH 
and TFR cells expressed much less CD49f complexed integrin 
compared to their pLN counterparts (Figure  3A; Figure S2 in 
Supplementary Material). Integrin α6 can pair with either β1 or 
β4. The latter is hardly expressed suggesting that in pLN but not 
PP TFH cells and more prominently TFR cells express integrin 
α6β1. In parallel, only pLN follicular T cells upregulated Plxnd1 
(Plexin D1), a surface bound receptor that controls clustering of 
β1-integrins thereby manipulating their avidity (37) (Figure 3B). 
Vice versa, a conspicuous upregulation of Asb2 was evident in 
PP cells, particularly in TFR cells. ASB-2 expression is sensitive 
to RA and enhances integrin-dependent adhesion by promot-
ing degradation of filamin (38). Additional genes modulating 
integrin binding activity were also regulated substantially during 
differentiation of follicular T cells such as Rasgpr2 (CalDAG-GEF) 
and Rasa3. These observations illustrate that integrin mediated 
functions drastically change during differentiation into TFH/TFR 
cells but also suggest that cells of PP and pLN origin differ from 
each other in these aspects. Moreover, a divergent upregulation 
of Cxcr3 (Figure  2D) and Ccr6 (Figure  3C) was detected in 
TFR cells of different origin. In periphery, the majority of TFR 
cells expressed high levels of CCR6 whereas PP TFR cells were 
CCR6lo/− (Figure 3D).
il4 and il21 are Produced by PP TFr 
cells
The cytokines IL4 (10) and IL21 (2, 12) are central players 
in the GC reaction and it was shown that they are expressed 
abundantly by TFH cells but not by TFR cells in periphery 
(18). In stark contrast, we found that PP TFR cells expressed 
substantial amounts of Il4 and to a lesser extent also Il21 
(Figure S4A in Supplementary Material). This was confirmed 
by intracellular detection of IL4 following PMA/ionomycin 
stimulation (Figures  4A,B). In these flow cytometry based 
cytokine analyses we discriminated between GL7+ and GL7− 
follicular cells and also performed a kinetic analysis determin-
ing cytokine production of T cell subsets at d6, d12, and d25 p.i. 
in pLN (Figure 4C). In periphery, highest amounts of IL4 were 
produced by TFH cells already at d6 p.i. but also PD1int cells 
produced IL4 predominantly early following immunization. 
As expected, peripheral FoxP3+ cells were virtually negative 
for IL4 at all time points analyzed (18). The regulatory circuits 
controlling IL4 and IL21 expression in TFH cells encompass 
the transcription factors Batf (BATF1) and Maf (C-MAF) and 
in both cases we observed increased levels of expression in PP 
TFR cells (6, 9, 39) (Figure S4B in Supplementary Material). 
It was reported that the CNS2 enhancer of the Il4 gene is of 
critical importance for transcription in TFH cells (40, 41) and 
it was demonstrated recently that BATF1 and C-MAF bind 
the CNS2 enhancer driving Il4 transcription (39). In addition, 
expression of Bach2 (BTBD25), a negative regular of BATF1 
activity, is uniformly downregulated in follicular T cells (42). 
Il4 expression is possibly supported in PP by abundant upregu-
lation of Cebpa (43) whereas that of Il21 may be fostered by 
IL27 (44) (Figure S4B in Supplementary Material). Elevated 
levels of Lag3, an IL27 responsive gene, may indicate increased 
availability of this cytokine in PP and also expression of Il27ra 
is higher in PP cells as compared to pLN cells supporting a 
role of IL27 in IL21 expression by PP TFR cells (Figure S4B in 
Supplementary Material).
FigUre 6 | Reviewing GL7 as marker for follicular T cells. (a) Microarray data from Peyer’s Patches (PP) for mRNA expression levels of the depicted genes in 
PD1hiGL− (open bars) versus PD1hiGL7+ (black bars) TFH cells. Same data source as in Figure 1e. Shown are mean ± SD. (B) Sketch of the two-photon converted 
regions. (c) Pictures of the converted regions inside the PP germinal center (GC) by two-photon microscopy (upper panels) and by epifluorescence microscopy (GC 
conversion lower left panel and interfollicular region lower right panel). Scale bar = 200 (upper panels) and 500 µm (lower panels). (D) Flow cytometry analysis of the 
illuminated PP with the converted cells boxed in the left panels. Gating was done as indicated. (e) Correlation between frequencies of GC B cells among all 
converted B cells and the frequencies of PD1hi cells among all converted CD4+ cells. Each dot represents a separate PP investigated. Black dots: conversion 
focused on GC, green dots: conversion focused on interfollicular regions, red dot: excluded from the analysis in (F) due to the low frequency of GC B cells. (F) Direct 
comparisons of frequencies of GL7+ cells among all PD1hi cells to those located only in converted GC of the same PP. (c–F) Data are from three independent 
experiments (n = 3). Unpaired two-tailed t-test was performed in (a) and paired two-tailed t-test was done in (F). ns: not significant (p > 0.05) and *p < 0.05.
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IL10 is expressed not only by Treg cells but also by TFH and 
TFR cells (15, 18). Expectedly, PP Treg cells expressed more IL10 
mRNA and protein than did pLN Treg cells (Figure  4; Figure 
S4A in Supplementary Material). IL10 expression culminated 
in peripheral TFH cells at day12 p.i. and declines thereafter 
(Figure  4C) whereas it is slightly increased in pLN TFR cells. 
Among follicular T  cells, a low percentage of PP TFH cells 
produced IL17 (Figure 4A). This would be in line with a report 
describing that in PP but not periphery TH17 cells can develop 
into TFH cells (45).
FigUre 7 | Further genes of interest. (a,B) Microarray data for mRNA expression levels of the depicted genes. Same data source as in Figure 1e. (c) Gating 
strategy illustrating definition of memory B cells in Peyer’s Patches (PP). (D) Data summary showing frequencies of memory B cells in PP of Sostdc1+/+ and 
Sostdc1−/− mice. Each dot represents one mouse. Shown are mean ± SD. (e) Determination of fecal IgA by ELISA, samples were tested in duplicates. Mean ± SD 
are given for each dilution step. (F) Left panel: Frequencies of PD1hi follicular T cells among all CD4+ cells in PP of Sostdc1+/+ and Sostdc1−/− mice according to the 
gating criteria shown in Figure 1a. Right panel: Frequencies of TFR cells among follicular cells of PP. Foxp3 was detected by intracellular stain as described in 
Section “Materials and Methods.” Shown are mean ± SD. One-way ANOVA followed by Tukey’s post hoc analysis was performed in (a,B) Data from three 
independent experiments (n = 7) were pooled and two-tailed t-tests were done in (D–F). N/A: not applicable, ns: not significant (p > 0.05), *p < 0.05, **p < 0.01, 
and ***p < 0.001.
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A substantial expression of IFNγ was detected in PD1int 
cells while IFNγ expression remained modest in PP/pLN TFH 
cells although levels increased over time in pLN (Figure  4C). 
Interestingly, in pLN but not in PP, a small fraction of TFR cells 
produced IFNγ (Figures  4A,C; Figure S4A in Supplementary 
Material). This parallels expression of Tbx21 (TBET) in these cells 
(Figure 2D). Evaluating IL4 versus IFNγ expression, we noted an 
increasing preference toward IFNγ production over time in pLN 
and thus a TH1 phenotype among PD1int cells as expected for 
a B6 background. But regarding PD1hi TFH cells, a significantly 
higher proportion of IL4+ cells existed reflecting the superior 
importance of this cytokine in the TFH driven GC reaction.
TFr cells of pln but not of PP Origin are 
il2 responsive
IL2 is a potent inhibitor of TFH cell differentiation (46) wherefore 
its signaling must be silenced. Consequently, as in naïve CD4 
T cells, expression of the high affinity IL2 receptor Il2ra (CD25) 
is absent or very low in TFH cells. However, CD25 is massively 
expressed by natural Treg cells from which TFR cells are derived. 
CD25 expression was found on TFR cells yet at decreased (35) 
or heterogeneous levels (18). Recently, peripheral CD25+ and 
CD25− TFR cells were analyzed separately suggesting that CD25− 
TFR cells represent matured cells (47). We also observed robust 
downregulation of Il2ra by TFR cells of PP but not of pLN origin 
even not at day 25 p.i. (Figure 5A). Flow cytometry confirmed 
that a substantial proportion of pLN TFR cells kept high levels of 
IL2RA on their surface but only a minority of PP TFR cells were 
CD25+ (Figure  5B; Figure S3 in Supplementary Material). In 
contrast to the peripheral CD25− TFR cells investigated by Wing 
et  al. (47), PP TFR cells remained largely unresponsive to IL2 
under stimulatory conditions but pLN TFR cells propagated to an 
extent as Treg cells (Figure 5C). The Il2ra expression pattern in 
the T cell subsets of interest here is similar to those observed for 
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Cish and Socs2 (Figure 2D) two important mediators of IL2 sign-
aling whose expression is induced by IL2 and that were already 
observed earlier to be regulated in follicular T cells (47, 48). This 
suggests that the IL2 signaling pathway is operative in vivo in pLN 
TFR cells but not in the vast majority of PP cells.
gl7 expression Does not Distinguish gc 
resident Follicular T cells
GL7 is considered as a marker distinguishing GC TFH cells (26). 
In PP, two distinct PD1hi populations, GL7− and GL7+, respec-
tively, exist in parallel at any time wherefore both were isolated 
and compared by transcriptome analysis. We failed to detect 
genes uniquely expressed in either population; only marginal 
differences exist between the expression of given genes of both 
populations that rarely reached statistical significance (Figure 6A; 
for further examples Figures 2 and 4). Therefore, we investigated 
the GL7 expression status of GC resident PD1hi cells. To this end, 
a mouse strain expressing a photoactivatable fluorescent protein 
was used (PA-GFP mouse). Intact PP were excised from the small 
intestine and a two-photon laser beam programmed to irradiate 
a predefined cuboid inside a GC or in the interfollicular T area 
(Figures  6B,C). Following photoconversion of the cells inside 
the cuboids, cells of the organs were analyzed by flow cytometry. 
The vast majority of GC-born photoactivated CD4 T cells were 
PD1hi but many of these were GL7− (Figure 6D, compare all cells 
displayed in the middle panels to converted cells only in the right 
panels). The percentage of CD4+PD1hi cells correlated with that 
of CD19+CD95+GL7+ GC B cells (Figures 6D,E) except for one 
case (red dot, neglected in Figure 6F) confirming that either a GC 
(black dots) or the interfollicular zone (green dots) was irradiated. 
The latter were virtually devoid of CD4+PD1hi cells or GC B cells 
(Figure 6D). Compared to all CD4+PD1hi cells inside a PP, these 
observations suggest an enrichment of PD1hiGL7+ cells inside the 
GC (Figure 6F) but the high proportion of GC PD1hiGL7− cells 
indicates that GL7 is not an exclusive GC T cell marker.
candidate genes
We identified a couple of genes that may be considered of 
primordial interest for further studies because they displayed a 
high degree of regulation that is paired in most cases with a thus 
far unrecognized or unique expression in cells of hematopoietic 
origin (Figure 7A). Among these are Smtn (smoothelin) as well 
as Actg2 (actin γ2), cytoskeletal proteins found mainly in muscle 
cells and that are highly upregulated in either TFH or TFR cells. 
Similarly, Popdc2 (POP2) is upregulated in TFH cells yet not in 
those of PP. Nrn1 (neuritin) and Penk (proenkephalin) represent 
two genes that were upregulated strongly and preferentially in 
TFR cells. Neuritin promotes axonal outgrowth and recently it 
was shown that another axonal guidance molecule, ephrin B1 is 
important for TFH cell function (49).
Also Sostdc1 (USAG1), a BMP antagonist (50), is profoundly 
upregulated in TFH cells and additionally in PP TFR cells 
(Figure 7B). In PP, absence of Sostdc1 increased frequencies of 
memory B cells (Figures 7C,D). Moreover, the fecal IgA content 
was elevated in Sostdc1−/− mice (Figure  7E) but follicular T 
cell frequencies remained unaltered (Figure  7F). Interestingly, 
Bmp7 is also upregulated in follicular cells (Figure  7B) and 
in  vitro BMP7 interfered with antibody production by human 
B cells (51). This documents an influence of USAG1on humoral 
immune responses yet further work will be needed to understand 
the underlying regulatory mechanisms.
DiscUssiOn
In search for genes important for differentiation and/or function 
of TFH and TFR cells, we focused on those displaying differential 
expression patterns compared to naïve CD4 T or Treg cells in 
PP and immunized pLN. This approach inherently neglects all 
genes where expression remains unchanged during follicular 
T  cell development but nevertheless is important for TFH or 
TFR biology. Moreover, we investigated the transcriptomes of 
follicular T cells at rather late time points following immuniza-
tion (d12 and d25) and not at earlier days (approximately at d7) as 
done in many other studies. We had chosen later time points for 
two reasons: (i) although detectable already at d6, we observed 
a separate and easy to gate PD1hiGL7+ population only at later 
time points and (ii) available data from literature indicated that 
upon immunization, the mass of TFR cells comes into existence 
later than the TFH cells (47, 52). Furthermore, we considered it 
important to apply a restrictive gating to focus on cells in most 
advanced stages of the follicular T cell pathway and to avoid con-
tamination with cell types that express PD1 at intermediate levels 
(e.g., preTFH cells, exhausted cells) or that exist in pLN already in 
steady state (activated Treg cells). This strategy was corroborated 
by the results following photo conversion of GC resident T cells, 
i.e., fully mature follicular cells, showing that the vast majority 
were PD1hi cells according to the gate criteria applied here.
Apart from well-studied genes central to TFH/TFR biology, we 
identified a collection of genes displaying a regulation that would 
bring in line their known effects in T  cells with those required 
for follicular T  cell development and/or function. For example, 
upmodulation was observed for Ptpn11 (SHP2, Figure 1E) that 
mediates the inhibitory activity of PD1 (53). Upregulation of PD1 
correlated with downmodulation of Satb1 coding a chromatin 
organizer that represses PD1 expression in T  cells (54). A con-
comitant expression of PD1 and other inhibitory receptors (e.g., 
Ctla4, Btla, Cd160, Tigit; Figure 2) over extended periods of time 
is associated with T cell exhaustion that would lead to a loss of 
effector functions in the long run (55). Exhaustion is provoked 
by a persistent antigen driven stimulation as met by T cells in the 
GC. Remarkably, exhausted CD4 T cells exist that produce IL10 
as well as IL21 and that express BCL6. In CD8 T cells, expression 
of Stx11 (syntaxin 11) that was upregulated in TFH and TFR cells, 
counteracts exhaustion (56). A trait follicular T cells may share 
with TH2 cells is the specific expression of Ptpn13 (FAP-1) that 
limits Fas/FasL-mediated apoptosis (57). Gadd45b (MyD118) 
expression is rapidly induced upon activation of CD4 T cells and 
its deficiency impairs cytokine production (58). Tbc1d4 encodes 
a Rab GTPase-activating protein involved in regulation of glucose 
uptake. A concurrent upregulation of Hif1a was found. HIF1α is 
a key factor regulating metabolism by upregulating expression 
of genes engaged in glycolysis (59). This was surprising because 
BCL6 was shown to suppress the expression of genes of the 
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glycolysis program in effector T cells (60) and glucose metabolism 
of TFH cells is considerably reduced compared to TH1 cells (61). 
By contrast, we observed a marked upregulation of BCL6 target 
genes such as Tpi1 (triosephoshate isomerase), Gapdh, or Pfkl 
(phosphofructokinase) in follicular T cells compared to naïve CD4 
and Treg cells (Figure 2B) suggesting that HIF1α may override 
BCL6 mediated repression in these particular cases. Evidence was 
provided that aerobic glycolysis is required for efficient cytokine 
production by T  cells (62) and an ongoing substantial glucose 
metabolism driven by HIF1α is further indicated by the notion 
that Mafg, a small MAF protein facilitating nuclear localization of 
HIF1A (63) is upregulated in follicular cells.
The results presented here revealed that the magnitude of gene 
regulation was very similar between TFH cells of PP and pLN 
although some variations and micro-milieu triggered divergences 
existed. Much more profound differences existed between the TFR 
cells of both compartments and one key feature of PP TFR cells is 
the almost complete absence of Il2ra expression and a concomi-
tant unresponsiveness to IL2. It was found recently that signature 
genes (e.g., Bcl6, Pdcd1, and Btla) were less well up-modulated in 
CD25+ TFR cells suggesting that they represent an intermediate 
stage whereas CD25− cells are matured GC resident TFR cells (47). 
Accordingly, we observed that regulation of some genes (e.g., Klf2, 
Tbc1d4) tended to completion at d25 but others did not follow such 
a scheme (e.g., Cxcr5, Hif1a) and also the signal for Il2ra remained 
high among d25 pLN TFR cells arguing against a progress in dif-
ferentiation toward CD25lo TFR cells. However, in pLN new Treg 
cells may be recruited continuously into the TFR pathway generat-
ing immature CD25+ cells, a process that would then not occur 
efficiently in PP in steady state with its well established chronic GC. 
At any rate, the existence of a high rate of CD25hi cells discriminated 
the pool of TFR cells of pLN from those of PP. In addition, only 
the latter were found to express Il4 and Il21 substantially and along 
with other noticeable differences (e.g., Vdr, Fut7, Ccr6, Nrn1) this 
gives rise to profound functional disparities. Thus, most activated 
B cells in PP would perform a switch to IgA that is propelled mainly 
by TGFβ but also other factors such as IL10, RA, and IL21 (64). 
Efficient IgA class switch takes place outside the GC in the SED 
that is rich in TGFβ-producing DC (65). To accomplish migration 
to the SED and interaction with DC, preGC B cells must express 
CCR6. Interestingly, we observed that pLN but not PP TFR cells 
prominently expressed this chemokine receptor. Therefore, in PP 
the IgA class switching cells might escape a fine-meshed control by 
TFR cells as met in the GC.
Notably, a temporal asymmetry exists regarding GC performance 
in periphery: at early time points, a broader spectrum of GC B cells 
with regard to antigen affinity as well as more memory B cells are 
generated whereas later on preferentially high affinity plasma cells 
are formed (66). Considering a delay in numbers and maturity, this 
would fit to a role of TFR cells suppressing GC B cell responses where 
only high affinity B cells would be able to overrule the increasing 
inhibition at later stages of the GC reaction (67). If this hypothesis 
is correct, it would be difficult to reconcile the role of the rather 
mature PP TFR cells with the commonly accepted scenario that the 
commensal microbiota-driven (chronic) GC responses in the PP 
would allow continuous generation of low-affinity GC B cells (64). 
However, we found that PP but not pLN TFR cells are capable to 
produce IL4 and IL21 although this contradicts their classical role, 
i.e., suppressing production of these cytokines by TFH cells (20). Of 
note, TFH-born IL4 efficiently drives plasma cell differentiation (68) 
and IL21endowes GC B cells to overcome an imprinted inhibition 
of propagation by TFR cells (69). We, therefore, speculate that by 
using these unique features PP TFR cells permit to some extent the 
proliferation of low-affinity GC B cells directly contacting them. For 
this purpose, also moderate levels of IL21production could be effec-
tive since the cytokine would be available at higher local concentra-
tions at the cell surface. Possibly, this also fuels autocrine mediated 
signaling. IL21 augments expression of Bcl6 that in turn impairs that 
of CD25 (70), a mechanism that may reinforce the more matured 
phenotype of PP TFR cells. Moreover, our observation of propaga-
tion incompetent CD25−IL4+IL21+ TFR cells could help explain 
why TFR cells of PP but not those of periphery can readily convert 
into TFH cells because they anticipate these TFH key features (24).
Taken together, our results unraveled may new aspects in TFH 
and TFR cell biology. This applies to genes of general relevance for 
follicular T cell function such as Hif1a, Il4, Il21, or the GL7 epitope 
but also genes supporting local peculiarities in function (e.g., 
Ccr6, Asb2, Il2ra, integrins and modulators of integrin function, 
Fut7). Interestingly, we discovered also genes that are more actively 
expressed in either of the TFH and TFR follicular subtypes, respec-
tively, and also a wealth of interesting candidate genes. However, 
the importance of these genes for follicular T cell biology awaits 
experimental validation although we were able to document an 
influence of Sostdc1 on efficiency of memory B cell generation in PP.
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